https://doctransparency.com/doctor/tx/amarillo/jenna-lane-1811376007
Medicare Enrolled

Dr. Jenna Lane, MD

Anesthesiology · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1901 MEDI PARK DR STE 2, Amarillo, TX 79106
8063507918
In practice since 2015 (10 years)
NPI: 1811376007 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lane

Dr. Jenna Lane is an anesthesiology in Amarillo, TX, with 10 years in practice. Based on federal Medicare data, Dr. Lane performed 5,243 Medicare services across 3,005 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lane received a total of $6,579 from 13 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lane is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 2% volume in TX$ $6,579 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,243
Medicare services
Top 2% in TX for anesthesiology
3,005
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~524 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Drug screening test1,404$60$600
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms1,058$190$600
Office visit, established patient (30-39 min)591$91$380
Assessment of emotional or behavioral problems347$3$17
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms347$236$750
New patient office visit (45-59 min)176$114$490
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level150$96$735
Injection of lower or sacral spine facet joint using imaging guidance, single level126$96$526
Injection of lower or sacral spine facet joint using imaging guidance, second level120$56$270
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint113$58$517
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint90$204$1,245
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level78$39$330
Compounded drug, not otherwise classified69$91$123
Office visit, established patient (20-29 min)68$63$267
Insertion of spinal neurostimulator electrode array through skin66$245$6,649
Electronic analysis reprogramming and refill of spinal canal drug infusion pump55$64$285
Injection of substance into middle or upper spine canal using imaging guidance45$78$798
Injection of upper or middle spine facet joint using imaging guidance, single level42$102$573
New patient office visit (30-44 min)39$78$328
Injection of upper or middle spine facet joint using imaging guidance, second level38$58$289
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint36$62$567
Injection of substance into lower spine canal using imaging guidance33$75$787
Injection, methylprednisolone acetate, 40 mg33$6$20
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint30$192$1,257
Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician22$68$290
Fluoroscopic guidance for needle placement21$21$342
Joint injection, major joint19$58$187
Office visit, established patient (10-19 min)15$40$164
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance12$74$489
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
18.4% medium
80.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,579
Total received (2018-2024)
Avg $940/year across 7 years
Top 6% in TX for anesthesiology
13
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,479 (98.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,124
2023
$601
2022
$3,743
2021
$199
2020
$520
2019
$135
2018
$257

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,816
Medtronic, Inc.
$1,747
Nevro Corp.
$430
Boston Scientific Corporation
$331
COMSORT, Inc
$100
BOSTON SCIENTIFIC CORPORATION
$43
Collegium Pharmaceutical, Inc.
$27
Lundbeck LLC
$17
ABBVIE INC.
$17
Amgen Inc.
$16
Haemonetics Corporation
$13
Edwards Lifesciences Corporation
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 91.1% of total payments
Associated products mentioned in payments ›
AMPERE · BRIDION · Belbuca · ClearSight System · Corlanor · ETERNA · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · IONICRF · LAMITRODE TRIPOLE · OCTRODE · PENTA · PROCLAIM · Proclaim IPG · QULIPTA · SPECTRA WAVEWRITER · SYNCHROMEDII · Senza Spinal Cord Stimulation System · TEG · VANTA ADAPTIVESTIM · VYEPTI · WaveWriter Alpha Prime 16
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for anesthesiology in TX.

Equivalent to $125 per 100 Medicare services performed
Looking for a anesthesiology in Amarillo?
Compare anesthesiologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologys nearby

Geographic Context

Anesthesiologys within 10 mi
33
Per 100K population
28.3
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lane is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 6%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lane experienced with drug screening test?
Based on Medicare claims data, Dr. Lane performed 1,404 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lane receive payments from pharmaceutical companies?
Yes. Dr. Lane received a total of $6,579 from 13 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lane's costs compare to other anesthesiologys in Amarillo?
Dr. Lane's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →